Index of reports
> Cases with Pyrexia (90)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 90 Next >>
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Oedema Peripheral, Anaemia, Abdominal Distension, Pyrexia, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk, qw
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
Ribavirin
Dosage: unk, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Nausea, Pyrexia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Start date: 2012-07-01
Ribasphere
Ribavirin
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Belgium on 2012-08-23
Patient:
Reactions: Nasal Obstruction, Fatigue, Anaemia, Condition Aggravated, Pyrexia, Oropharyngeal Pain, Streptococcal Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, qw
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-07-31
Rebetol
Dosage: 1000 mg, bid
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-07-31
Victrelis
Dosage: 2400 mg, tid
Indication: Hepatitis C
Start date: 2012-04-17
End date: 2012-07-31
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-23
Patient:
Reactions: Abdominal Pain, Diarrhoea, Presyncope, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-07-23
End date: 2012-08-04
Rebetol
Dosage: 1400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-23
End date: 2012-08-04
Other drugs received by patient: Wellbutrin; Acetylsalicylic Acid SRT; Nebivolol HCL; Gabapentin
Possible PEG-Intron side effects in
Reported by a physician from Spain on 2012-08-22
Patient:
Reactions: Drug Ineffective, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms
Drug(s) suspected as cause:
Intron A
Dosage: unk
Start date: 1999-01-01
Intron A
Dosage: 3 mu, tiw
Start date: 1992-09-01
End date: 1993-03-01
Intron A
Dosage: unk
Start date: 1996-02-01
End date: 1996-05-01
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-03-06
Ribavirin
Dosage: 1200 mg, qd
Start date: 2012-02-01
End date: 2012-03-13
Ribavirin
Dosage: 1200 mg, qd
Start date: 1994-03-01
Ribavirin
Dosage: unk
Start date: 1996-02-01
End date: 1996-05-01
Ribavirin
Dosage: unk
Start date: 1999-01-01
Telaprevir
Dosage: 750 mg, q8h
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-03-10
Other drugs received by patient: Verapamil; Trandolapril; Moxonidine; Telmisartan
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Stomatitis, Anaemia, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Allopurinol
Dosage: 100 mg, once
Administration route: Oral
End date: 2012-03-06
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-21
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-02-07
End date: 2012-02-13
Rebetol
Administration route: Oral
Start date: 2012-02-14
End date: 2012-02-28
Rebetol
Dosage: 800 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-06
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-28
Other drugs received by patient: Magmitt
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-22
Patient:
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 microgram per kilogram
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-05-08
PEG-Intron
Dosage: 1.5 microgram per kilogram
Start date: 2012-05-23
End date: 2012-07-18
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-02-26
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-27
End date: 2012-03-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-28
End date: 2012-05-08
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-23
End date: 2012-07-24
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-05-02
Other drugs received by patient: Celestamine Combination; Loxonin; Famotidine; Celestamine Combination; Loxonin; Allopurinol
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Metabolic Acidosis, Dyspnoea, Diarrhoea, Hypophagia, Bronchitis, Pyrexia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Boceprevir
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded MK-5172
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded Post Trial Therapy
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded PRE Trial Therapy
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: f
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: h
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: c
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: g
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: e
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: d
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: b
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: 4 df, tid
Administration route: Oral
Start date: 2012-02-08
End date: 2012-06-24
Blinded Therapy
Blinded Therapy
Blinded Therapy
Blinded Therapy
Indication: Hepatitis C
Blinded Therapy
PEG-Intron
Indication: Hepatitis C
PEG-Intron
Dosage: 0.5 ml, qw
Administration route: Oral
Start date: 2012-01-10
End date: 2012-06-19
Peginterferon Alfa-2B
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Placebo
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Rebetol
Dosage: 3 df, qam
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-10
Rebetol
Dosage: 3 df, qpm
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-06
Rebetol
Dosage: 2 df, qpm
Administration route: Oral
Start date: 2012-04-07
End date: 2012-06-24
Rebetol
Dosage: 2 df, qam
Administration route: Oral
Start date: 2012-05-01
End date: 2012-06-24
Rebetol
Dosage: 3 df, qam
Administration route: Oral
Start date: 2012-04-17
End date: 2012-04-30
Rebetol
Dosage: 2 df, qam
Administration route: Oral
Start date: 2012-04-11
End date: 2012-04-16
Ribavirin
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Other drugs received by patient: Protonix; Paxil; Protonix; Lisinopril; Paxil; Lisinopril
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-15
Patient:
Reactions: Haemoglobin Decreased, Heart Rate Decreased, Pyrexia, Blood Pressure Decreased, Renal Failure Acute
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-18
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Other drugs received by patient: Digoxin; Losartan Potassium and Hydrochlorothiazide; Warfarin Sodium; Bisoprolol Fumarate; Lasix; Coniel; Warfarin Sodium; Bisoprolol Fumarate; Losartan Potassium and Hydrochlorothiazide; Digoxin; Losartan Potassium and Hydrochlorothiazide; Lasix; Coniel
Possible PEG-Intron side effects in
Reported by a physician from Italy on 2012-08-14
Patient:
Reactions: Abdominal Pain, Diarrhoea, Presyncope, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-07-23
End date: 2012-08-04
Rebetol
Dosage: 1400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-23
End date: 2012-08-04
Other drugs received by patient: Wellbutrin; Pantoprazole Sodium; Nebivolol HCL; Gabapentin
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient:
Reactions: Pyrexia, Hyperhidrosis
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-24
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-24
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Pain, Polyuria, Headache, Pyrexia, Myalgia, Mood Altered, Neck Pain, Chest Pain, DRY Mouth, Breath Odour, Dizziness, Depression, Sinus Congestion, Nausea, Anaemia, Glucose Tolerance Impaired, Hypoaesthesia, Oropharyngeal Discomfort, Tremor, Mental Impairment, Sleep Disorder, Visual Impairment, Asthenia, Feeling Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-03-09
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-03-09
Other drugs received by patient: Valium; Advil; Xanax; Ambien
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Abdominal Pain, Fatigue, Bone Pain, Ocular Hyperaemia, Pyrexia, Constipation
Drug(s) suspected as cause:
PEG-Intron
Dosage: redipen,150 microgram per 0.5 ml ,4 syringe per pack
Rebetol
Dosage: 200 mg, unk
Telaprevir
Dosage: 375 mg, unk
Other drugs received by patient: Acetaminophen / Hydrocodone Bitartrate; Magnesia [milk OF]; Amitiza; Etodolac; Alka-Seltzer
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: Pyrexia, Neutropenia, Neutrophil Count Decreased, Erythema, Thrombocytopenia, Oropharyngeal Discomfort, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.72 mcg/kg/week
Start date: 2012-01-25
End date: 2012-01-25
PEG-Intron
Dosage: 100 mcg/week
Start date: 2012-06-12
End date: 2012-06-25
PEG-Intron
Dosage: 1.45 mcg/kg/week
Start date: 2012-06-12
End date: 2012-06-12
PEG-Intron
Dosage: 1.44 mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-01-18
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-01-25
Rebetol
Dosage: 400 mg, bid
Administration route: Oral
Start date: 2012-06-12
End date: 2012-06-25
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-01-25
Other drugs received by patient: Urso 250; Urso 250
Possible PEG-Intron side effects in male
Reported by a consumer/non-health professional from Brazil on 2012-08-07
Patient: male, weighing 93.0 kg (204.6 pounds)
Reactions: Weight Decreased, Drug Ineffective, Pain, Pyrexia, Skin Reaction, Abdominal Discomfort, Weight Increased, Vascular Rupture, Hallucination, Cutaneous Lupus Erythematosus, Cough, Nervousness, Anaemia, Rhinitis, Muscular Weakness, Aggression, Dysgeusia, Insomnia, Alopecia, Anal Haemorrhage, Influenza
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Peginterferon Alfa-2A
Indication: Hepatitis C
Start date: 2012-07-16
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Victrelis
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-16
End date: 2012-07-16
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-06
Patient:
Reactions: Dyspnoea, Retching, Nausea, Pyrexia, Constipation, Fatigue, Palpitations, Dizziness, Asthenia, Influenza Like Illness
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
PEG-Intron
Dosage: 150 ?g, unknown
Indication: Hepatitis C
Rebetol
Dosage: 200 mg, unknown
Indication: Hepatitis C
Other drugs received by patient: Estradiol (+) Norethindrone; Tylenol (Caplet); Neupogen; Prochlorperazine; Procrit; Prozac
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient:
Reactions: Night Sweats, Abdominal Pain, Contusion, Chills, Wheezing, Pyrexia, Change of Bowel Habit, Constipation, Hyperhidrosis, Joint Stiffness, Hepatomegaly, Laboratory Test Abnormal, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Dizziness, Melaena, White Blood Cell Count Decreased, Dyspnoea, Hepatic Fibrosis, Haemorrhoids, Incorrect Dose Administered, Laceration, Hepatic Steatosis, Haemoglobin Decreased, Impaired Healing, Diarrhoea, Arthralgia, Insomnia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 microgram, qd
Pegasys
Dosage: 180mcg,once a week
Rebetol
Dosage: 1200 mg, qd
Victrelis
Dosage: 200mg,4tablets,three times a day
Other drugs received by patient: Allegra-D 12 Hour; Omeprazole; Milk Thistle; Zolpidem Tartrate; Citalopram Hydrobromide; Echinacea (Unspecified)
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Greece on 2012-08-01
Patient:
Reactions: Dyspnoea, Fatigue, Pulmonary Embolism, Pleural Effusion, Pyrexia, Cardiac Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 unk, unk
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2012-07-03
Rebetol
Dosage: 1200 mg, unk
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2012-07-03
Possible PEG-Intron side effects in 75 year old male
Reported by a individual with unspecified qualification from Japan on 2012-07-31
Patient: 75 year old male
Reactions: Rhabdomyolysis, Henoch-Schonlein Purpura, Platelet Count Decreased, Oropharyngeal Pain, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: dosage is uncertain.
Indication: Hepatitis C
Start date: 2006-12-01
Rebetol
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-01
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Japan on 2012-07-31
Patient:
Reactions: Drug Eruption, Pyrexia, Erythema Multiforme, Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-15
End date: 2012-05-09
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-10
End date: 2012-05-14
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-15
End date: 2012-05-17
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-05-17
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-15
End date: 2012-03-29
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-30
End date: 2012-04-12
Telavic
Administration route: Oral
Start date: 2012-05-10
End date: 2012-05-14
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-15
End date: 2012-05-09
Other drugs received by patient: Prednisolone; Prednisolone; Diclofenac Sodium; Betamethasone; Clobetasol Propionate; Olopatadine HCL; Prednisolone; Prednisolone; Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Streptococcus Faec; Biofermin (Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Strepto
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Pneumonia, Nausea, Musculoskeletal Discomfort, Headache, Pyrexia, Eating Disorder, Dysgeusia, Diarrhoea, Skin Odour Abnormal, Heart Rate Increased, Chest Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-27
Possible PEG-Intron side effects in 54 year old female
Reported by a pharmacist from United States on 2012-07-27
Patient: 54 year old female, weighing 113.5 kg (249.7 pounds)
Reactions: Nausea, Chills, Urinary Tract Infection, Pyrexia, Hyperhidrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Paxil; Ibuprofen; M.v.i.; Ferrous Sulfate TAB; Ribavirin; Tylenol
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-27
Patient:
Reactions: Bedridden, Chest Discomfort, Vomiting, Nausea, Retching, Anaemia, Oropharyngeal Pain, Pyrexia, DRY Skin, Anxiety, Weight Increased, Thinking Abnormal, Dehydration
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-01-31
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-01-31
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-28
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-26
Patient:
Reactions: Pyrexia, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, unk
Indication: Hepatitis C
Start date: 2012-01-01
Rebetol
Possible PEG-Intron side effects in
Reported by a physician from Greece on 2012-07-24
Patient:
Reactions: Dyspnoea, Fatigue, Pleural Effusion, Pulmonary Embolism, Pyrexia, Cardiac Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 unk, unk
Indication: Hepatitis C
End date: 2012-07-03
Rebetol
Dosage: 1200 microgram, unk
Indication: Hepatitis C
End date: 2012-07-03
Possible PEG-Intron side effects in
Reported by a physician from Spain on 2012-07-20
Patient:
Reactions: Drug Ineffective, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms
Drug(s) suspected as cause:
Intron A
Dosage: unk
Start date: 1999-01-01
Intron A
Dosage: 6 miu, tiw, lymphoblastoid injection
Start date: 1993-01-01
Intron A
Dosage: unk
Start date: 1996-02-01
End date: 1996-05-01
Intron A
Dosage: 3 mu, tiw
Indication: Hepatitis C
Start date: 1992-09-01
End date: 1993-03-01
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-03-06
Rebetol
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 1994-03-01
Rebetol
Dosage: unk
Start date: 1999-01-01
Rebetol
Dosage: 1200 mg, qd
Start date: 2012-02-01
End date: 2012-03-13
Rebetol
Dosage: unk
Start date: 1996-02-01
End date: 1996-05-01
Telaprevir
Dosage: 750 mg, q8h
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-03-10
Other drugs received by patient: Moxonidine; Verapamil; Telmisartan; Trandolapril
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-07-17
Patient:
Reactions: Neutropenia, Pyrexia, Thrombocytopenia, Erythema, Neutrophil Count Decreased, Oropharyngeal Discomfort, Leukopenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.72 mcg/kg/week
Start date: 2012-01-25
End date: 2012-01-25
PEG-Intron
Dosage: 100 mcg/week
Start date: 2012-06-12
End date: 2012-06-25
PEG-Intron
Dosage: 100 microgram, qw
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-01-18
Rebetol
Dosage: 400 mg, bid
Administration route: Oral
Start date: 2012-06-12
End date: 2012-06-25
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-01-25
Telaprevir
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-01-25
Other drugs received by patient: Urso 250
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 57 year old female, weighing 85.7 kg (188.6 pounds)
Reactions: Night Sweats, White Blood Cell Count Decreased, Dyspnoea, Wheezing, Chills, Haemorrhoids, Anaemia, Laceration, Pyrexia, Joint Stiffness, Fatigue, Diverticulum, RED Blood Cell Count Decreased, Arthralgia, Impaired Healing, Insomnia, Dizziness, Injury, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 mcg once a week
Indication: Hepatitis C
Pegasys
Dosage: 180 mcg once a week
Indication: Hepatitis C
Ribavirin
Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
Indication: Hepatitis C
Start date: 2011-09-04
Ribavirin
Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
Indication: Hepatitis C
Start date: 2011-11-07
Victrelis
Dosage: 200 mg 4 tabs three times a day orally
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
Other drugs received by patient: Echinacea; Citalopram Hydrobromide; Milk Thistle; Zolpidem; Vitamin E; Omeprazole; Allegra-D 12 Hour
Possible PEG-Intron side effects in 50 year old male
Reported by a physician from Japan on 2012-07-05
Patient: 50 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Weight Decreased, Drug Eruption, Pruritus, Pyrexia, Headache, Somnolence, Erythema, Treatment Noncompliance, Hyperuricaemia, Malaise, Abdominal Distension, Decreased Appetite, Dyspnoea, Nausea, Rash, Haemoglobin Decreased, Insomnia, Hypophagia, Gait Disturbance
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5;1.3 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2012-02-28
End date: 2012-03-06
PEG-Intron
Dosage: 1.5;1.3 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2012-03-13
PEG-Intron
Dosage: 1.5;1.3 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-21
Rebetol
Dosage: 800;600;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
Rebetol
Dosage: 800;600;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-27
End date: 2012-04-09
Rebetol
Dosage: 800;600;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-20
End date: 2012-01-20
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-01-19
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-21
End date: 2012-04-09
Other drugs received by patient: Confatanin; Famotidine; Famotidine; Xyzal; Clobetasol Propionate; Clobetasol Propionate; Confatanin
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05
Patient: female
Reactions: Fatigue, Insomnia, Dizziness, Pyrexia, Blood Glucose Increased
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2012-06-06
Ribavirin
Indication: Hepatitis C
Start date: 2012-06-06
Page 1 Next >>
|